News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • DoorDash will buy Instacart for about $17 billion, creating a consolidated grocery-delivery leader and requiring regulatory approval.
  • Microsoft beat on cloud, while Alphabet underwhelmed, leaving tech futures lower and increasing sector dispersion.
  • Merck beat Q3 estimates, raised guidance, and shares rose in premarket trading.
  • Sterling slipped as the dollar held firm ahead of U.S. core PCE inflation and GDP releases, keeping traders cautious.
  • Andritz reported Q3 order intake below estimates amid project volatility but kept full-year sales and EBITA margin guidance.
  • Analysts urge buying TSMC ahead of a 2nm ramp, citing record capex and a $60–64 billion plan to secure advanced AI manufacturing.
  • Lebanese farmers returned to fields to harvest olives near Israeli troops despite shelling, highlighting persistent security risks in southern Lebanon.

Latest Articles

Funding Growth From Production: Mako Mining's Expansion Trade Setup

Funding Growth From Production: Mako Mining's Expansion Trade Setup

Mako Mining ($MAKO) is trading just under $10 with a market cap near $863M. Technical momentum is constructive and the company’s San Albino focus positions it to convert operating cash flow into additional projects. This trade favors a directional long with defined entry, stop and target tied to operational and news catalysts over the next 180 trad…

FDA eGFR Readout Backs a Speculative Long on Vera Therapeutics

FDA eGFR Readout Backs a Speculative Long on Vera Therapeutics

Vera Therapeutics' recent regulatory win and underlying kidney function data create a buyable dip for traders willing to accept biotech execution and commercial risks. Market cap near $2.3B prices in success, but short interest, healthy liquidity and an improving technical setup make a defined-risk long trade attractive over a mid-term horizon.

Cisco After the Drop: Buy the AI-Driven Dip, Not the Fear

Cisco After the Drop: Buy the AI-Driven Dip, Not the Fear

Cisco's recent pullback looks like an overreaction. The company just raised its AI order target to $9 billion and still generates ~$11.8 billion of free cash flow annually while trading at a mid-30s P/E. This trade idea lays out an entry at $112.41 with tight risk control and a $125 target over a mid-term horizon.

Valneva After VALOR: Why the Lyme Royalty Shift Reprices the Stock

Valneva After VALOR: Why the Lyme Royalty Shift Reprices the Stock

Valneva's partnership with Pfizer and the messy VALOR readout shifted the firm's path from a potential commercial blockbuster to a royalty/milestone-oriented business. That change reduces binary clinical risk but also recasts valuation. With a market cap near $676M, recent product sales and a still-meaningful cash cushion, the shares offer an asymm…

WeRide: Tactical Long After a Convincing Q2 - Plan for a Mid-Term Bounce

WeRide: Tactical Long After a Convincing Q2 - Plan for a Mid-Term Bounce

WeRide's latest quarter surprised the market and reset expectations for commercialization pace. We like a tactical long here: the company is showing improving revenue and better-than-feared unit economics, while market sentiment remains fragile. The trade is sized for a mid-term rebound and uses tight risk controls to respect headline risk in auton…

Why External TPU Sales Could Re-Rate Alphabet - A Practical Trade Plan

Why External TPU Sales Could Re-Rate Alphabet - A Practical Trade Plan

Alphabet is already pouring capital into AI infrastructure. Turning internal TPU (Tensor Processing Unit) capacity into a commercial product flips a cost center into recurring, high-margin revenue. The balance sheet, cash flow, and Cloud momentum support a long position. Trade plan: enter $341.36, target $400.00, stop loss $320.00 on a 180-trading-…